Replies to post #674106 on NorthWest Biotherapeutics Inc (NWBO)

[exwannabe]

Getting DCVax approved in the UK establishes the treatment as legit and creates a revenue stream that NWBO sorely needs. If the UK is the fastest place for approval then that is where NWBO should go.

Why would anybody expect the UK to be fastest for a revenue stream?

We finally have our first example of the MHRA actually being first to approve, CASGEVY. Yet the launch rollout is targeting the US followed by EU and Saudi. Unclear if it will ever launch in the UK because it is expensive.

Of all the other drugs approved the last 1+ year, MHRA was a laggard. So why there first?

[iclight]

Because the Adcom would bring up the change in trial after everyone was already treated , illegitimate control arm, problems with the blended data at interim vs final data, and all the other issues oncologists and bears have brought up in comments about the JAMA article.

Adcom won’t be made up of company shills that don’t even understand trials.